Sera Prognostics Announces Pricing For PreTRM Test, The Only Broadly Validated Blood Test To Assess Risk Of Preterm Birth
SALT LAKE CITY, Dec 2, 2021 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative p…
